280 related articles for article (PubMed ID: 35806168)
1. Comprehensive Analysis of N6-Methyladenosine (m6A) Writers, Erasers, and Readers in Cervical Cancer.
Condic M; Ralser DJ; Klümper N; Ellinger J; Qureischi M; Egger EK; Kristiansen G; Mustea A; Thiesler T
Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35806168
[TBL] [Abstract][Full Text] [Related]
2. N6-methyladenosine RNA modification (m6A) is of prognostic value in HPV-dependent vulvar squamous cell carcinoma.
Condic M; Thiesler T; Staerk C; Klümper N; Ellinger J; Egger EK; Kübler K; Kristiansen G; Mustea A; Ralser DJ
BMC Cancer; 2022 Sep; 22(1):943. PubMed ID: 36050747
[TBL] [Abstract][Full Text] [Related]
3. The potential role of RNA N6-methyladenosine in primary Sjögren's syndrome.
Xiao Q; Wu X; Deng C; Zhao L; Peng L; Zhou J; Zhang W; Zhao Y; Fei Y
Front Med (Lausanne); 2022; 9():959388. PubMed ID: 36465909
[TBL] [Abstract][Full Text] [Related]
4. m6A readers, writers, erasers, and the m6A epitranscriptome in breast cancer.
Petri BJ; Klinge CM
J Mol Endocrinol; 2023 Feb; 70(2):. PubMed ID: 36367225
[TBL] [Abstract][Full Text] [Related]
5. m6A-Related Genes Contribute to Poor Prognosis of Hepatocellular Carcinoma.
Zou Y; Jiang G; Xie Y; Li H
Comput Math Methods Med; 2022; 2022():2427987. PubMed ID: 36339682
[TBL] [Abstract][Full Text] [Related]
6. RNA m6A modification, signals for degradation or stabilisation?
Wei G
Biochem Soc Trans; 2024 Apr; 52(2):707-717. PubMed ID: 38629637
[TBL] [Abstract][Full Text] [Related]
7. Function of N6-Methyladenosine Modification in Tumors.
Zhang N; Zuo Y; Peng Y; Zuo L
J Oncol; 2021; 2021():6461552. PubMed ID: 34858499
[TBL] [Abstract][Full Text] [Related]
8. RNA m6A methylation regulators in sepsis.
Zhu L; Zhang H; Zhang X; Xia L
Mol Cell Biochem; 2023 Sep; ():. PubMed ID: 37659034
[TBL] [Abstract][Full Text] [Related]
9. Fusaric acid decreases p53 expression by altering promoter methylation and m6A RNA methylation in human hepatocellular carcinoma (HepG2) cells.
Ghazi T; Nagiah S; Chuturgoon AA
Epigenetics; 2021 Jan; 16(1):79-91. PubMed ID: 32631113
[TBL] [Abstract][Full Text] [Related]
10. Comprehensive analysis of m6A related gene mutation characteristics and prognosis in colorectal cancer.
Jiang T; Xing L; Zhao L; Ye Z; Yu D; Lin S
BMC Med Genomics; 2023 May; 16(1):105. PubMed ID: 37194014
[TBL] [Abstract][Full Text] [Related]
11. Function and prognostic value of N6-methyladenosine-modified RNAs in lung adenocarcinoma.
Liu J; Zheng Z; Zhong J
J Gene Med; 2023 Jan; 25(1):e3454. PubMed ID: 36282144
[TBL] [Abstract][Full Text] [Related]
12. Function and clinical significance of N6-methyladenosine in digestive system tumours.
Huang J; Shao Y; Gu W
Exp Hematol Oncol; 2021 Jul; 10(1):40. PubMed ID: 34246319
[TBL] [Abstract][Full Text] [Related]
13. Association of N6-methyladenosine readers' genes variation and expression level with pulmonary tuberculosis.
Li HM; Tang F; Wang LJ; Huang Q; Pan HF; Zhang TP
Front Public Health; 2022; 10():925303. PubMed ID: 36072379
[TBL] [Abstract][Full Text] [Related]
14. Characteristics of n6-methyladenosine (m6A) regulators and role of FTO/TNC in scleroderma.
Yu Y; Liang C; Tang Q; Shi Y; Shen L
Gene; 2024 Feb; 894():147989. PubMed ID: 37972699
[TBL] [Abstract][Full Text] [Related]
15. New roles of N6-methyladenosine methylation system regulating the occurrence of non-alcoholic fatty liver disease with N6-methyladenosine-modified MYC.
Cheng W; Li M; Zhang L; Zhou C; Yu S; Peng X; Zhang W; Zhang W
Front Pharmacol; 2022; 13():973116. PubMed ID: 36120320
[TBL] [Abstract][Full Text] [Related]
16. Comprehensive characterization of tumor microenvironment and m6A RNA methylation regulators and its effects on PD-L1 and immune infiltrates in cervical cancer.
Ji H; Zhang JA; Liu H; Li K; Wang ZW; Zhu X
Front Immunol; 2022; 13():976107. PubMed ID: 36091006
[TBL] [Abstract][Full Text] [Related]
17. METTL3 potentiates progression of cervical cancer by suppressing ER stress via regulating m6A modification of TXNDC5 mRNA.
Du QY; Huo FC; Du WQ; Sun XL; Jiang X; Zhang LS; Pei DS
Oncogene; 2022 Sep; 41(39):4420-4432. PubMed ID: 35987795
[TBL] [Abstract][Full Text] [Related]
18. Dynamic Alteration Profile and New Role of RNA m6A Methylation in Replicative and H
Wu F; Zhang L; Lai C; Peng X; Yu S; Zhou C; Zhang B; Zhang W
Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012545
[TBL] [Abstract][Full Text] [Related]
19. m6A regulators are differently expressed and correlated with immune response of pancreatic adenocarcinoma.
Zhang T; Sheng P; Jiang Y
J Cancer Res Clin Oncol; 2023 Jul; 149(7):2805-2822. PubMed ID: 35780396
[TBL] [Abstract][Full Text] [Related]
20. Transcriptome-wide profiling identifies colon cancer-associated m6A transcripts and potential RNA methyl modifiers.
Ramasamy D; Thippannah M; Maharajan HRP; Balaiah M; Seshadri RA; Kodous AS; Herceg Z; Mehta A; Rao AKDM; Mani S
Mol Biol Rep; 2024 Feb; 51(1):299. PubMed ID: 38345740
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
